EquityZen Growth Technology Fund LLC - Series 2250
Raised
$500K
Investors
30
Min Invest
$10,000
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 2250 is a Delaware-based pooled investment fund that raised $500K from 30 investors under Rule 506(b) and Section 3(c) exemptions, with a $10K minimum investment. Filed March 31, 2026 by EquityZen Advisors and Philip Haslett, this entity is part of the EquityZen platform, which operates 1,889 related pre-IPO investment vehicles.
This pre-IPO fund follows EquityZen's typical Series SPV structure with a retail-accessible $10K minimum, significantly lower than institutional pre-IPO vehicles that often require $100K+. The 506(b) exemption and 3(c) designation are standard for pooled pre-IPO investment funds targeting accredited investors without general solicitation.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
